Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile
General Stock Board Listed Company Profile
Code:
Industry:
Local/Foreign Company:
4743 ONENESS BIOTECH
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Shan-Nei Huang Shan-Nei Huang Shan-Nei Huang 02-27031098 11F., No.236, Sec. 4, Xinyi Rd., Da' an Dist., Taipei City 106, TaiwanTaipei, Taiwan 2011/09/23
Industry Main Business
Biotechnology and Medical Care
Oneness Biotech has multiple drug development pipelines focusing on the botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified. One prominent program undertaken and finished is a human phase II clinical trial that was approved from US FDA and TFDA indicating for the treatment of diabetic foot ulcers. It was further approved by TFDA to conduct a phase III clinical trial. We are validating and developing lead extracts/compounds in targeting rheumatoid arthritis, cancer and DM. We are developing these new drugs and actively collaborate with international partners in three disease areas: diabetic wound managements and DM, anti-arthritis and anti-cancers. By taking these innovative technologies and product lines into global markets, we dedicated to bring the best to medicines in improving human health and treating diseases.
 
Market Information ( 2020/07/08 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
1917.416 433.50  380.50  433.50  39.00  1666 0.54 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2020/07/08)
TPEx measures
adopted
(2020/07/08)
With warrants Can be shorted or margined? Detail
Normal N Y Y N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.